Abstract
Recent imaging and postmortem studies suggest that impaired connectivity is involved in the pathophysiology of schizophrenia and major affective disorders. We investigated the presynaptic proteins complexin (Cx) I and Cx II in postmortem prefrontal cortex in schizophrenia (n = 13; six suicide, seven nonsuicide), major depression (n= 11, all suicide) and controls (n = 11) with an enzyme-linked immunoadsorbent assay (ELISA). Overall analysis indicated a significant difference between groups (F = 3.93, P = 0.007). Cx I (enriched in inhibitory terminals) was decreased 33% in schizophrenia (26% in schizophrenia/nonsuicide, 42% in schizophrenia/suicide) and 27% in major depression. Cx II (enriched in excitatory terminals) was not significantly different. Analysis of the ratio of Cx II/Cx I was carried out as an indication of the balance of excitatory to inhibitory terminals. A significant difference between groups (ANOVA, F = 6.42, P = 0.005) was observed. The mean value of Cx II/Cx I was significantly increased by 34% in schizophrenia (26% in schizophrenia/nonsuicide and 43% in schizophrenia/suicide) and by 32% in depression compared with control (Student-Newman-Keuls test, P = 0.05). Immunoreactivities of the two complexins were highly correlated in all groups. However, compared with controls and depression, samples from cases with schizophrenia appeared to have relatively less Cx I for similar amounts of Cx II. Immunocytochemical studies of rat frontal cortex after 3 weeks treatment with chlorpromazine, trifluoperazine or haloperidol revealed no differences in complexins, synaptophysin, SNAP-25, syntaxin or VAMP in comparison with animals treated with vehicle. Alterations of complexins may contribute to the molecular substrate for abnormalities of neural connectivity in severe mental disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weinberger DR . Schizophrenia: from neuropathology to neurodevelopment Lancet 1995 346: 552–557
Drevets WC . Neuroimaging studies of mood disorders Biol Psychiatry 2000 48: 813–829
Baumann B, Bogerts B . The pathomorphology of schizophrenia and mood disorders: similarities and differences Schizophrenia Res 1999 39: 141–148
Andreasen NC . Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology Science 1997 275: 1586–1593
Rajkowska G, Selemon LD, Goldman-Rakic PS . Neuronal and glial somal size in the prefrontal cortex Arch Gen Psychiatry 1998 55: 215–224
Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia J Neurol Neurosurg Psychiatry 1998 65: 446–453
Glantz LA, Lewis DA . Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia Arch Gen Psychiatry 2000 57: 65–73
Honer WG, Young C, Falkai P . Synaptic pathology. In: Harrison PJ, Roberts GW (eds) The Neuropathology of Schizophrenia Oxford University Press: Oxford 2000 105–136
Davidsson P, Gottfries J, Bogdanovic N, Ekman R, Karlsson I, Gottfries C-G et al. The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains Schizophrenia Res 1999 40: 23–29
Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P . Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex Neuron 2000 28: 53–67
Honer WG, Falkai P, Bayer TA, Xie J, Hu L, Li H-Y et al. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness Cerebral Cortex 2001 (in press)
Honer WG . Assessing the machinery of mind: synapses in neuropsychiatric disorders J Psychiatry Neurosci 1999 24: 116–121
Ishizuka T, Saisu H, Odani S, Abe T . Synaphin: a protein associated with the docking/fusion complex in presynaptic terminals Biochem Biophys Res Comm 1995 213: 1107–1114
Takahashi S, Yamamoto H, Matsuda Z, Ogawa M, Yagyu K, Taniguchi T et al. Identification of two highly homologous presynaptic proteins distinctly localized at the dendritic and somatic synapses FEBS Lett 1995 368: 455–460
McMahon HT, Missler M, Li C, Südhof TC . Complexins: cytosolic proteins that regulate SNAP receptor function Cell 1995 83: 111–119
Yamada M, Saisu H, Ishizuka T, Takahashi H, Abe T . Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types Neuroscience 1999 93: 7–18
Ono S, Baux G, Sekiguchi M, Fossier P, Morel NF, Nihonmatsu I et al. Regulatory roles of complexins in neurotransmitter release from mature presynaptic nerve terminals Eur J Neurosci 1998 10: 2143–2152
Harrison PJ, Eastwood SL . Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia Lancet 1998 352: 1669–1673
Harrison PJ, Eastwood SL . Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs Mol Psychiatry 1999 5: 525–532
Honer WG, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ . Synaptic and plasticity associated proteins in anterior frontal cortex in severe mental illness Neuroscience 1999 91: 1247–1255
Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia Neuroscience 1997 78: 99–110
Kadota K, Kadota T . Isolation of coated vesicles, plain synaptic vesicles, and flocculent material from a crude synaptosome preparation of guinea pig whole brain J Cell Biol 1973 58: 135–151
Paxinos G, Watson C . The Rat Brain in Stereotaxic Coordinates Academic Press: San Diego 1986
Young CE, Arima K, Xie J, Hu L, Beach TG, Falkai P et al. SNAP-25 deficit and hippocampal connectivity in schizophrenia Cereb Cortex 1998 8: 261–268
Benes FM, McSparren J, Bird ED, Vincent SL, SanGiovanni JP . Deficits in small interneurons in schizophrenic cortex Arch Gen Psychiatry 1991 48: 996–1001
Benes FM, Vincent SL, Marie A, Khan Y . Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects Neuroscience 1996 75: 1021–1031
Beasley CL, Reynolds GP . Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics Schizophrenia Res 1997 24: 349–355
Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL et al. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry Proc Nat Acad Sci USA 1996 93: 9985–9990
Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL et al. Hypofrontality in schizophrenia: disturbed dysfunctional circuits in neuroleptic-näive patients Lancet 1997 349: 1730–1734
Rajkowska G . Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells Biol Psychiatry 2000 48: 766–777
Eastwood SL, Harrison PJ . Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders Brain Res Bull 2001 55: 569–578
Eastwood SL, Burnet PWJ, Harrison PJ . Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain Synapse 2000 36: 167–177
Nakahara T, Motomura K, Hashimoto K, Ueki H, Gotoh L, Hondo H et al. Long-term treatment with haloperidol decreases the mRNA levels of complexin I, but not complexin II, in rat prefrontal cortex, nucleus acumbens and ventral tegmental area Neurosci Lett 2000 290: 29–32
Eastwood SL, Burnet PWJ, Harrison PJ . Striatal synaptophysin and haloperidol-induced synaptic plasticity NeuroReport 1994 5: 677–680
Lidow MS, Song Z-M, Castner SA, Allen PB, Greengard P, Goldman-Rakic PS . Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex Biol Psychiatry 2001 49: 1–12
Eastwood SL, Cairns NJ, Harrison PJ . Synaptophysin gene expression in schizophrenia Br J Psychiatry 2000 176: 236–242
Acknowledgements
WGH was supported by a Scientist Award from the Canadian Institutes of Health Research, and KS by a Fellowship from the PEARL Program. Grant support was provided by CIHR (MT14037), NARSAD and the National Institutes of Mental Health (MT46745, MH40210 and MH60877). Drs Joel Kleinman and Manuel Casanova provided tissue samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sawada, K., Young, C., Barr, A. et al. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 7, 484–492 (2002). https://doi.org/10.1038/sj.mp.4000978
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000978
Keywords
This article is cited by
-
Vesicle trafficking and vesicle fusion: mechanisms, biological functions, and their implications for potential disease therapy
Molecular Biomedicine (2022)
-
Alterations in brain synaptic proteins and mRNAs in mood disorders: a systematic review and meta-analysis of postmortem brain studies
Molecular Psychiatry (2022)
-
Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures
Molecular Psychiatry (2019)
-
Genetic association analysis of microRNA137 and its target complex 1 with schizophrenia in Han Chinese
Scientific Reports (2017)
-
Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer’s disease
Acta Neuropathologica (2017)